A. Grein
Impact in
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis
- Microbiology top 10%
Papers in ⓘ
- Pharmacology 16
- Microbial Natural Products and Biosynthesis 16
-
- Chemical Synthesis and Analysis 3
- Co-authors
- C. Spalla (13 shared papers)Giuseppe Cassinelli (8 shared papers)Federico Arcamone (6 shared papers)P. Orezzi (3 shared papers)Samuel P. Meyers (1 shared paper)Anna Maria Casazza (3 shared papers)A Sanfilippo (1 shared paper)Aurelio Di Marco (2 shared papers)
- Journals
- The Journal of Antibiotics (5 papers)Archives of Microbiology (4 papers)Biotechnology and Bioengineering (2 papers)Cellular and Molecular Life Sciences (2 papers)Advances in applied microbiology (1 paper)
- Partner nations
- ItalySwitzerlandGermany
In The Last Decade
A. Grein
20 papers receiving 773 citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Pharmacology 299
- Microbiology 10
- Toxicology 44
- Biotechnology 98
- Oncology 209
Countries citing papers authored by A. Grein
This map shows the geographic impact of A. Grein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Grein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Grein more than expected).
Fields of papers citing papers by A. Grein
This network shows the impact of papers produced by A. Grein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Grein. The network helps show where A. Grein may publish in the future.
Co-authors
The 23 scholars most cited alongside A. Grein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius Hit paper breakdown → | 1969 | 477 |
| 2 | 2000 | 54 | |
| 3 | 1958 | 52 | |
| 4 | 1967 | 34 | |
| 5 | 1987 | 33 | |
| 6 | 1954 | 32 | |
| 7 | 1982 | 32 | |
| 8 | 1978 | 26 | |
| 9 | 1969 | 19 | |
| 10 | 1985 | 13 | |
| 11 | 1970 | 12 | |
| 12 | 1982 | 11 | |
| 13 | 1981 | 11 | |
| 14 | 1978 | 10 | |
| 15 | 1980 | 9 | |
| 16 | 1974 | 8 | |
| 17 | 1955 | 5 | |
| 18 | 1990 | 4 | |
| 19 | 1987 | 4 | |
| 20 | 1970 | 3 |
About A. Grein
A. Grein is a scholar working on Pharmacology, Molecular Biology, Plant Science, Organic Chemistry and Small Animals, having authored 22 papers that have together received 850 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (16 papers), Cancer Treatment and Pharmacology (3 papers), Synthesis and Biological Activity (3 papers), Infectious Diseases and Mycology (3 papers), Chemical Synthesis and Analysis (3 papers), Synthetic Organic Chemistry Methods (2 papers), Plant Pathogens and Fungal Diseases (2 papers) and Actinomycetales infections and treatment (2 papers). The work is most often cited by research in Pharmacology (299 citations), Microbiology (10 citations), Toxicology (44 citations), Biotechnology (98 citations) and Oncology (209 citations). A. Grein has collaborated with scholars based in Italy, Switzerland and Germany. Frequent co-authors include C. Spalla, Giuseppe Cassinelli, Federico Arcamone, P. Orezzi, Samuel P. Meyers, Anna Maria Casazza, A Sanfilippo, Aurelio Di Marco, Graziella Pratesi and A. Minghetti. Their work appears in journals such as The Journal of Antibiotics, Archives of Microbiology, Biotechnology and Bioengineering, Cellular and Molecular Life Sciences and Advances in applied microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.